curasan AG has appointed Christine Uekert as chief financial officer with effect from April 3, 2017. Uekert succeeds Dr. Erwin Amashaufer, who is retiring, in the position as a Management Director. At the same time, Uekert will become the CFO of the American subsidiary curasan Inc. in Research Triangle Park, North Carolina, in order to ensure the rapid implementation of its planned integration in the commercial structures of curasan AG and the efficient coordination of all financial processes.

Uekert has extensive experience in the areas of finance and controlling in internationally operative, innovative and especially growing companies. Most recently, Ms. Uekert, who holds a degree in business economics, was the chief financial officer at Centogene AG. There, she was responsible for developing the financial architecture and expansion strategy, and successfully supported growth corresponding to more than a tenfold increase in sales within five years.

Prior to that, she held several management positions at biotechnology and technology companies such as ProBioGen AG, OD-OS GmbH, SPM Technologies GmbH and SAP Systems Integration AG. To ensure a smooth transition, Dr. Erwin Amashaufer, who has headed finance and administration of the company since 2004 and who is now retiring, will assist her in the first few weeks.